FDA Approved Medical Products for:

Sickle cell disease

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Hydroxyurea
Trade Name
(Manufacturer Name)
Droxia®
(Bristol-Myers Squibb Pharmaceutical Research Institute)
Indication
The FDA has approved this product to be used in this manner.
To reduce the frequency of painful crises and to reduce the need for blood transfusions in adult patients with sickle cell anemia with recurrent moderate to severe painful crises (generally at least 3 during the preceding 12 months).
More Information about this product Drug Information Portal
Medline Plus Health Information